Gyeonggi-do, South Korea

Hong-Sub Lee

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 10.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Yongin-si, KR (2021)
  • Gyeonggi-do, KR (2017 - 2023)
  • Youngin-si, KR (2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hong-Sub Lee: Pioneering Advancements in Metabolic Disease Treatment

Introduction: Hong-Sub Lee, an esteemed inventor located in Gyeonggi-do, South Korea, has made significant contributions to the field of pharmaceuticals, with a notable portfolio of 8 patents. His work focuses on developing innovative compounds aimed at treating various metabolic disorders, demonstrating his commitment to advancing healthcare solutions.

Latest Patents: Among Lee's recent patents is the invention involving isoxazole derivatives as nuclear receptor agonists. This invention provides methods for treating metabolic diseases, cholestatic liver diseases, or organ fibrosis. It highlights the administration of a therapeutically effective amount of a pharmaceutical composition containing isoxazole derivatives or their variants.

Additionally, Lee has patented phenyl propionic acid derivatives, which exhibit GPR40 agonist activity. These compounds are pivotal in modulating blood glucose levels and improving glucose-dependent insulin secretion mechanisms, making them promising candidates for managing type 2 diabetes without the risk of hypoglycemia.

Career Highlights: Throughout his career, Hong-Sub Lee has collaborated with prestigious organizations, including Il Dong Pharmaceutical Co., Ltd. and Ildong Pharm Co., Ltd. His work in these companies has facilitated the development and commercialization of several innovative pharmaceutical products, reinforcing his impactful presence in the industry.

Collaborations: Lee has worked alongside notable colleagues such as Jae-Hoon Kang and Kyung-Mi An. Their collaborative efforts have contributed to advancing research and innovation in drug development, further enhancing Lee's reputation as a leading inventor in the field.

Conclusion: Hong-Sub Lee exemplifies the spirit of innovation in pharmaceuticals, with his patents reflecting his dedication to addressing critical health challenges. His contributions signify a meaningful impact on the treatment of metabolic diseases, paving the way for exciting developments in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…